Riskpilot← Back to searchSign inGet full accessFLOAT BIOPRO AS
ASActiveOrg 979734603Storgata 25, 6002 ÅlesundEngineering activities and related technical consultancy · NACE 7112Est. 19981 employees
Revenue 2024
NOK 2K
0% vs 2023
EBITDA margin
-4366.4%
-946% vs 2023
Equity ratio
-445.5%
Financial strength
Net profit 2024
NOK -109K
-949% vs 2023
| Revenue | NOK 2K | +0% |
| EBITDA | NOK -109K | -946% |
| Net profit | NOK -109K | -949% |
| Total assets | NOK 20K | -1% |
| Equity | NOK -89K | -558% |
| Employees | 1 | — |
Legal name
FLOAT BIOPRO AS
Org number
979734603
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
16. april 1998
Share capital
NOK 2 073 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utvikling og drift av teknisk utstyr for tørking, fortrinnsvis patenterbart, samt salg av teknisk utstyr for tørking, kjøp, foredling og salg av fisk, skalldyr, trevirke, biobrensel, korn mv. Og varer i annen næringsvirksomhet, herunder gjennom aksjetegning eller på annen måte delta i andre selskap eller foretak.
Address
Storgata 25, 6002 Ålesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 69 | 13 | 2 | 2 |
| Staff expenses | −0 | −0 | −3 | −0 | −0 |
| EBITDA | −112 | 209 | −7 | −10 | −109 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −112 | 209 | −7 | −10 | −109 |
| Net financials | −3 | −19 | −0 | 0 | 0 |
| Profit before tax | −114 | 191 | −7 | −10 | −109 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −114 | 191 | −7 | −10 | −109 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 283 | 82 | 32 | 20 | 20 |
| Equity | −321 | 37 | 30 | 19 | −89 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 604 | 46 | 2 | 1 | 109 |
| Total debt | 604 | 46 | 2 | 1 | 109 |
EBITDA margin
-4366.4%
This company
15.8%
Market median
-27735% vs market
20202024
Equity ratio
-445.5%
This company
38.2%
Market median
-1266% vs market
20202024
Return on equity
-10857500.0%
This company
18.4%
Market median
-59008252% vs market
20202024
Net profit margin
-4363.9%
This company
8.1%
Market median
-53975% vs market
20202024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20202024
Debt / equity
1.22×
This company
0.62×
Market median
-97% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 9.84% | 9.84% | 2022 | |
| Company | 8.39% | 8.39% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FLOAT BIOPRO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kåre Mikal Mikalsen | Board of Directors | 0 companies |
| Svein Inge Ringdal | Chairman | 0 companies |
| André Werner Asbjørnsen | Board of Directors | 0 companies |